Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Hydrochloride, Pilocarpine
2. Isopilocarpine
3. Isoptocarpine
4. Nitrate, Pilocarpine
5. Ocusert
6. Pilocarpine
7. Pilocarpine Hydrochloride
8. Pilocarpine Mononitrate, (3s-cis)-isomer
9. Pilocarpine, Monohydrochloride, (3s-cis)-isomer
10. Salagen
1. 148-72-1
2. Pilagan
3. Pilofrin
4. Pilocarpine Mononitrate
5. Pilocarpine Nitrate Salt
6. Pilocarpine (nitrate)
7. Pilocarpinum Nitricum
8. Pilocarpine Subnitrate
9. Pilocarpine Nitrate [usp]
10. Nsc-757282
11. 2(3h)-furanone, 3-ethyldihydro-4-[(1-methyl-1h-imidazol-5-yl)methyl]-, (3s,4r)-, Nitrate (1:1)
12. Mls000069669
13. M20t465h6j
14. (3s,4r)-3-ethyl-4-((1-methyl-1h-imidazol-5-yl)methyl)dihydrofuran-2(3h)-one Nitrate
15. Smr000058498
16. Pilocarpine Nitrate (usp)
17. (3s,4r)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one;nitric Acid
18. Pilocarpini Nitras
19. Pilocarpin Nitrate
20. 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, (3s-cis)-, Mononitrate
21. Sr-01000075339
22. P. V. Carpine Liquifilm
23. Unii-m20t465h6j
24. Sr-01000000054
25. 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, (3s,4r)-, Nitrate (1:1)
26. Prestwick_282
27. Einecs 205-723-7
28. Pilagan (tn)
29. Mfcd00078497
30. Pilocarpine, Mononitrate
31. Regid855878
32. Opera_id_1243
33. Schembl41889
34. Spectrum1500487
35. Chembl1213136
36. Pilocarpine Nitrate [mi]
37. Hms501b20
38. Dtxsid80883277
39. Hms1569i20
40. Hms1920h14
41. Hms2091p18
42. Hms2096i20
43. Hms2235p11
44. Hms3262p22
45. Hms3713i20
46. Pharmakon1600-01500487
47. Pilocarpine Nitrate [vandf]
48. Hy-b1006
49. Pilocarpine Nitrate [mart.]
50. Pilocarpinum Nitricum [hpus]
51. Tox21_500960
52. Ccg-38830
53. Nsc757282
54. Pilocarpine Nitrate [usp-rs]
55. Pilocarpine Nitrate [who-dd]
56. Pilocarpine Nitrate [who-ip]
57. Akos016009842
58. Cs-4503
59. Lp00960
60. Nsc 757282
61. Ncgc00094261-01
62. Ncgc00261645-01
63. Pilocarpine Nitrate [ep Impurity]
64. Pilocarpine Nitrate [ep Monograph]
65. Pilocarpini Nitras [who-ip Latin]
66. Pilocarpine Nitrate [usp Monograph]
67. Eu-0100960
68. D05478
69. P 6628
70. T71804
71. Pilocarpine Nitrate Salt, >=98% (tlc), Powder
72. Sr-01000000054-7
73. Sr-01000075339-2
74. Sr-01000075339-5
75. Pilocarpine Nitrate Salt, Tested According To Ph.eur.
76. Pilocarpine Nitrate, Meets Usp Testing Specifications
77. Q27283365
78. Sr-01000075339-10
79. Pilocarpine Nitrate, British Pharmacopoeia (bp) Reference Standard
80. Pilocarpine Nitrate, European Pharmacopoeia (ep) Reference Standard
81. Pilocarpine Nitrate, United States Pharmacopeia (usp) Reference Standard
82. Pilocarpine Nitrate For System Suitability, European Pharmacopoeia (ep) Reference Standard
83. Pilocarpine Nitrate, Pharmaceutical Secondary Standard; Certified Reference Material
84. 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, (3s,4r)-, Mononitrate
Molecular Weight | 271.27 g/mol |
---|---|
Molecular Formula | C11H17N3O5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 271.11682065 g/mol |
Monoisotopic Mass | 271.11682065 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 270 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Miotics
Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)
Muscarinic Agonists
Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Pilocarpine Nitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pilocarpine Nitrate, including repackagers and relabelers. The FDA regulates Pilocarpine Nitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pilocarpine Nitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pilocarpine Nitrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pilocarpine Nitrate supplier is an individual or a company that provides Pilocarpine Nitrate active pharmaceutical ingredient (API) or Pilocarpine Nitrate finished formulations upon request. The Pilocarpine Nitrate suppliers may include Pilocarpine Nitrate API manufacturers, exporters, distributors and traders.
click here to find a list of Pilocarpine Nitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pilocarpine Nitrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Pilocarpine Nitrate active pharmaceutical ingredient (API) in detail. Different forms of Pilocarpine Nitrate DMFs exist exist since differing nations have different regulations, such as Pilocarpine Nitrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pilocarpine Nitrate DMF submitted to regulatory agencies in the US is known as a USDMF. Pilocarpine Nitrate USDMF includes data on Pilocarpine Nitrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pilocarpine Nitrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pilocarpine Nitrate suppliers with USDMF on PharmaCompass.
A Pilocarpine Nitrate CEP of the European Pharmacopoeia monograph is often referred to as a Pilocarpine Nitrate Certificate of Suitability (COS). The purpose of a Pilocarpine Nitrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pilocarpine Nitrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pilocarpine Nitrate to their clients by showing that a Pilocarpine Nitrate CEP has been issued for it. The manufacturer submits a Pilocarpine Nitrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pilocarpine Nitrate CEP holder for the record. Additionally, the data presented in the Pilocarpine Nitrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pilocarpine Nitrate DMF.
A Pilocarpine Nitrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pilocarpine Nitrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pilocarpine Nitrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pilocarpine Nitrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pilocarpine Nitrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pilocarpine Nitrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pilocarpine Nitrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pilocarpine Nitrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pilocarpine Nitrate suppliers with NDC on PharmaCompass.
Pilocarpine Nitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pilocarpine Nitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pilocarpine Nitrate GMP manufacturer or Pilocarpine Nitrate GMP API supplier for your needs.
A Pilocarpine Nitrate CoA (Certificate of Analysis) is a formal document that attests to Pilocarpine Nitrate's compliance with Pilocarpine Nitrate specifications and serves as a tool for batch-level quality control.
Pilocarpine Nitrate CoA mostly includes findings from lab analyses of a specific batch. For each Pilocarpine Nitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pilocarpine Nitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Pilocarpine Nitrate EP), Pilocarpine Nitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pilocarpine Nitrate USP).
LOOKING FOR A SUPPLIER?